Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



A Phase I / II Study of AMG 510 in Combination With MVASI in Patients With Advanced, Unresectable or Metastatic KRAS G12C Mutant NSCLC With Asymptomatic Brain Metastasis

Lung

This is a multicenter, non-randomized, open-label, phase I / II study to evaluate the safety and tolerability of AMG 510 plus MVASI in subjects with advanced KRAS p.G12C mutant non-small cell lung cancer (NSCLC) with small, untreated brain metastases.
Lung
I/II
Iams, Wade
NCT05180422
VICCTHOP21115

Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)

Multiple Cancer Types

To evaluate the safety and tolerability of sotorasib administered in investigational regimens in adult participants with KRAS p.G12C mutant advanced solid tumors.
Miscellaneous, Phase I
I
Iams, Wade
NCT04185883
VICCPHI2025

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: